Investigational Site Number :2500007

Bordeaux 33076

1 studies enrolling now · 4 studies all time

What they study most

Glycogen Storage Disease Type II;Pompe's Disease, Neurodermatitis, Polyneuropathy, Inflammatory Demyelinating, Chronic, Transplant Rejection

Studies at this site

• Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP — Enrolling by invitation
• BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) — Running, not enrolling
• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2) — Completed
• Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease — Completed